Actively Recruiting
Study of Skin Changes During Covid-19 Infection Focusing on Chilblains
Led by Centre Hospitalier Universitaire de Nice · Updated on 2026-06-29
30
Participants Needed
1
Research Sites
321 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying skin manifestations that occur during Covid-19 infection, with a special focus on chilblains, a frequent and specific type of acral lesion. The goal is to better understand these skin symptoms and their underlying causes, which may involve direct viral effects or vascular issues like microthrombosis or vasculitis. Insights from this study could also help explain other systemic symptoms seen in Covid-19 patients. The study involves characterizing chilblains through clinical and dermoscopic examination. Researchers will also perform non-invasive vascular assessments and analyze immune and blood clotting factors in patients diagnosed with Covid-19. These evaluations are conducted at the CHU of Nice to explore the relationship between skin signs and vascular or immune changes. Participants will have their skin symptoms monitored clinically over three months. Additional assessments include histology, biological tests, and non-invasive vascular examinations during this period. The study aims to gather a detailed profile of skin manifestations and related vascular and immune responses, contributing to a better understanding of Covid-19s effects on the skin and possibly systemic health.
CONDITIONS
Brief Title
Assessment of Chilbains Occuring During Covid-19 Infection
Research Team
C
Cynthia CAILLON
S
Sylvie MALERBA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here